https://www.selleckchem.com/pr....oducts/simnotrelvir.
The protective ventilation group had lower levels of cf-DNA in arterial (p= 0.02) and hepatic venous blood (p= 0.03) compared with the controls. Transhepatic differences in cf-DNA were lower in the protective group, compared with the controls (p= 0.03). No differences between the groups were noted as regards the transcerebral, transsplanchnic or the transpulmonary cf-DNA differences. Protective ventilation suppresses arterial levels of cf-DNA. The liver seems to be a net contributor to the systemic cf-DNA levels, but this effect is